MarketPeel
Insider Trading Intelligence
Pricing
…
KA

Kamil Ali-jackson

PDSB
DIRECTOR · PDS BIOTECHNOLOGY CORP · CIK 0001654337
FILING MIX · LIFETIME47%/53%
BUYS
39
SELLS
44
TOTAL VALUE
$3.94M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
225,215
AVG SELL PX
$21.04
TRADE KIND
SHOWING 83 / 83
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Kamil Ali-jackson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+100.00%-10.50%-0.50%-10.00%-8.05%—
14d18+100.00%-9.61%-0.27%-9.34%-9.90%—
30d18+100.00%-13.29%+1.89%-15.18%-12.45%—
60d18+100.00%-27.79%+4.31%-32.10%-34.52%—
90d18+100.00%-28.29%+6.42%-34.70%-41.92%—
180d18+94.44%-32.52%+11.01%-43.52%-41.34%—
1y18+94.44%-44.26%-0.05%-44.20%-47.83%—
2y18+94.44%-60.39%+2.80%-63.18%-64.44%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PDSB · 54,876 shares · as of Jan 12, 2026
013,71927,43841,15754,876202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 39 buys / 44 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RIGL
RIGEL PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,500$35.00$87.5K10,125Jun 22, 2026Jun 24, 2026 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,500$29.17$72.9K12,625May 26, 2026May 28, 2026 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,750——15,125May 15, 2026May 19, 2026 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
54,876——54,876Jan 12, 2026Mar 3, 2026 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
22,700——22,700Jun 11, 2025Jun 11, 2025 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
3,000——3,000May 23, 2025May 28, 2025 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,500——9,375May 23, 2025May 28, 2025 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 24, 2024Jun 25, 2024 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,000——30,000May 25, 2024May 29, 2024 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,000——68,750May 25, 2024May 29, 2024 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jul 14, 2023Jul 17, 2023 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 28, 2022Jun 29, 2022 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
18,750——18,750May 20, 2022May 23, 2022 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,500——22,500May 20, 2022May 23, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
3,875——118,571Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
27,905——0Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,875——0Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
7,100——0Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
6,638——153,114Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
27,905——146,476Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
6,638——0Jan 3, 2022Jan 5, 2022 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
7,100——160,214Jan 3, 2022Jan 5, 2022 ↗View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
120,000——120,000Dec 16, 2021Dec 17, 2021 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Jun 17, 2021Jun 17, 2021 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASE
11,764$8.50$100.0K11,764Jun 15, 2021Jun 17, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
9,492$21.96$208.4K122,196Jun 3, 2021Jun 4, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,387$22.31$53.3K131,688Jun 2, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
12,732$21.51$273.8K134,075Jun 2, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,517$22.32$56.2K146,807Jun 2, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
12,483$21.50$268.4K149,324Jun 2, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
33,189——176,807Jun 1, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
33,189——0Jun 1, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
9,746$22.72$221.4K167,061Jun 1, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
5,254$23.57$123.9K161,807Jun 1, 2021Jun 2, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,100$23.99$50.4K143,618May 7, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
5,416$10.66$57.7K149,034May 7, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,316$23.23$77.0K145,718May 7, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
5,416——0May 7, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
11,898$23.32$277.4K146,720May 6, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
15,000$10.66$159.9K158,618May 6, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,102$23.86$74.0K143,618May 6, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
15,000——5,416May 6, 2021May 7, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
15,000$10.66$159.9K158,618May 5, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
14,502$23.97$347.6K144,116May 5, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
15,000——20,416May 5, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
498$24.36$12.1K143,618May 5, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
15,000$10.66$159.9K158,618May 4, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,279$24.47$31.3K143,618May 4, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
13,721$23.61$323.9K144,897May 4, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
15,000——35,416May 4, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
15,000$10.66$159.9K158,618May 3, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
4,339$24.91$108.1K143,618May 3, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
10,661$24.46$260.7K147,957May 3, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
15,000——50,416May 3, 2021May 5, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALEGRANT
Gift
7,500——114,696Mar 11, 2021Nov 22, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,906$23.25$44.3K143,618Mar 2, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
6,637——145,524Mar 2, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
6,637——19,914Mar 2, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
17,175——34,350Mar 1, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
17,175——143,821Mar 1, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
4,934$24.06$118.7K138,887Mar 1, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
99,500——99,500Mar 1, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,400——28,400Mar 1, 2021Mar 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,875——3,875Feb 1, 2021Feb 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,318$21.35$28.1K126,646Feb 1, 2021Feb 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
3,875——127,964Feb 1, 2021Feb 3, 2021 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,734——0Dec 15, 2020Dec 17, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
498$4.59$2.3K124,089Dec 15, 2020Dec 17, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,734——124,587Dec 15, 2020Dec 17, 2020 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
3,033——3,033Jun 23, 2020Jun 25, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
9,534$1.32$12.6K122,853Jun 1, 2020Jun 3, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
33,188——33,189Jun 1, 2020Jun 3, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
33,188——132,387Jun 1, 2020Jun 3, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
17,175——51,525Mar 2, 2020Mar 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
4,779$1.26$6.0K99,199Mar 2, 2020Mar 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,551——26,551Mar 2, 2020Mar 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
92,928——92,928Mar 2, 2020Mar 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
17,175——103,978Mar 2, 2020Mar 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
66,377——66,377Mar 2, 2020Mar 4, 2020 ↗View →
PDSB
PDS BIOTECHNOLOGY CORP
PURCHASEGRANT
Stock grant
9,000——9,000Feb 21, 2020Feb 24, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
3,875——7,750Feb 3, 2020Feb 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
3,875——88,121Feb 3, 2020Feb 4, 2020 ↗View →
ACRS
ACLARIS THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,318$1.28$1.7K86,803Feb 3, 2020Feb 4, 2020 ↗View →
Other insiders · PDSB
Loading peer insiders…
About this filer
CIK 0001654337
ROLE
Director
PRIMARY
PDSB
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001654337DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback